Innovotech Insider Trading
TSX-V IOT
1
All Trades
1
Significant
0
Notable
0
Clusters
0
Repeat
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Innovotech | ██████ | ████████ | ██-███-26 | ███,███ | $█.██ | $███,███ | ███,███ | ██% | ████████ |
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Innovotech | Tam, David | Director | 14-May-25 | 695,000 | $0.21 | $144,534 | 2,477,616 | 39% | Significant |
Stock Chart
Related Companies to Explore
Company Info
Innovotech is a Canadian biotechnology company that develops and commercializes antimicrobial testing technologies and services. The company operates primarily from Edmonton, Alberta, and focuses on creating solutions to combat antimicrobial resistance and biofilm-related infections. Innovotech’s core business involves providing specialized testing services to pharmaceutical, medical device, and biotechnology companies worldwide.
The company’s flagship technology is the MBEC Assay, a standardized method for testing antimicrobial efficacy against biofilms formed by bacteria and fungi. This testing platform helps clients develop and evaluate antimicrobial products, coatings, and treatments. Innovotech also offers the Calgary Biofilm Device, which creates reproducible biofilms for research and product development purposes.
Innovotech serves clients across North America, Europe, and Asia, providing contract research services from its specialized laboratories. The company has established partnerships with major pharmaceutical companies and research institutions. Innovotech’s testing methodologies have been adopted as industry standards by organizations including ASTM International. The company has been involved in developing antimicrobial solutions for various applications, including medical devices, wound care products, and infection control technologies.